Author
1163 posts
On Monday, Alphabet reported its Q4 results. Though its profits managed to rise, some aspects of the company’s performance such as Google’s advertising business looked disappointing. GOOGL stock went down.
Porsche’s advertising is back to the Super Bowl. The ad shows the Taycan and is aimed to build awareness for the car which may help to attract new customers and probably beat Tesla in the market competition.
Panasonic Corp reported higher operating profit boosted by cost cuts and an improvement at the joint battery business with Tesla Inc. However, despite good results, Panasonic stock price is moving down.
The latest Bitcoin rally comes along with an increase in the price of gold which has climbed as investors fret over the spreading coronavirus. Some Bitcoin analysts have pointed to geopolitical uncertainty being the cause for Bitcoin’s latest move higher.
Brexit is officially done. Now Boris Johnson is to use a high-profile speech on Monday to set out his plans to negotiate a comprehensive free trade agreement between UK and EU to an unprecedentedly tight deadline of 31 December, which he insists he will not extend.
Colgate-Palmolive (CL) reports that organic sales increased by 5.0% in Q4 to easily beat the 3.0% consensus mark. Now the company expects the sales growth of at least 4% to 6%.
The revenues of Visa and Mastercard have been significantly growing over the last 5 fiscal years. Now the companies have all the chances to hit $1 trillion in market capitalization.
Citigroup is one of the biggest six U.S. banks that decided to have a robo-advisor. In the case of Citigroup, it will be free for customers with at least $50,000 in investments or deposits at the bank.
XRP is still in an odd spot: nobody knows for sure whether or not the asset is a commodity or security or even neither. Some people, like Ben Askren, believe that it is just a scam.
In November Netflix released a documentary about the coronavirus-like epidemic and Bill Gates spoke there like a real Nostradamus. He said we should invest more in the development of vaccines against such diseases.